Fri, Aug 29, 2014, 11:48 AM EDT - U.S. Markets close in 4 hrs 12 mins

Recent

% | $
Quotes you view appear here for quick access.

Cytori Therapeutics, Inc. Message Board

  • crkenmore crkenmore Oct 3, 2012 3:16 PM Flag

    Cytori- " Anticipation " could be the Theme Song

    This may or may not be the next REGN or SRPT, but the longer term prospects are likely to be positive. As others have already indicated the short term funding shortfall is a serious overhang. The stock is down 1.32% so far today, five consecutive days below the $ 4.75 Sept. 21 close. By contrast the S&P is higher. What will happen to the stock on a down market day?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • First of all, you need to watch your userid's before posting...

      Second, your posts show that you don't know Cytori... Just look at 2010 and 2011 and compare it to SPX...

      Having said that, you have a very good chance to make your 20-40% profit, but be very careful here, one more good news and you are F^%&^ed.

      That's why we play this game, exciting...

    • ***The stock is down 1.32% so far today, five consecutive days below the $ 4.75 Sept. 21 close. ***

      I dont get that point at all and personally view $4.50 as a watch point.

      *** By contrast the S&P is higher.***

      Soooo ???? We are not in the S&P !! Yet !!! LOL

      ***What will happen to the stock on a down market day?***

      There will be both buyers and sellers !
      What do I win if I am right ?
      WST has set a tradition you know !!!!!!!!!!

      • 1 Reply to myownhedgefund
      • Myownhedgefund

        Here is the relevance., sorry if it was not more clear or more obvious. Company specific attainment of milestones, funding, partnering, and clinical has an direct impact on the share price. Since Cytx is a small company, absent releases from the firm or changes to stock analysts ratings, the macro environment as represented by the S&P or the more targeted XBI ETF ( both closing higher today ) influences investor sentiment. If Cytx's funding challenges were firmly in the rear view mirror and they were in Stage 3 FDA approval, the impact of "externalities" would be moderate and short term. While clinical progress is inherently long and drawn out, the funding overhang makes a quick snap back from large share price declines more problematic, as evidenced by the past weeks volatility. My point is if the market does not reward CYTX with share appreciation when investors are buying, what will happen when the company faces "fighting the tape" ? IMO share price will be highly susceptible to large up/down swings until sustainable funding is secured. Until then, I prefer to add to my positions at a safer entry of 50 day SMA $ 3.16 to September 27 low $ 3.61. If Cytx secures funding in Q-4 the price will be higher, but the risk of precipitous declines lower. I personally prefer the later scenario.

 
CYTX
1.392+0.012(+0.87%)11:42 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.